2024
“Peace of Mind” After Mastectomy: A Scoping Review
Hamid S, Bakkila B, Schultz K, Grimshaw A, Gunderson C, Godfrey E, Lee C, Berger E, Rosenberg S, Greenup R. “Peace of Mind” After Mastectomy: A Scoping Review. Annals Of Surgical Oncology 2024, 31: 5168-5179. PMID: 38717543, DOI: 10.1245/s10434-024-15360-3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsContralateral prophylactic mastectomyUnilateral mastectomyBreast-conserving therapyAverage-risk womenInclusion criteriaPsychosocial well-beingProspective cohort studyBackgroundMany womenProphylactic mastectomyScoping reviewMethodsNine databasesWhite/Caucasian womenCohort studyStudy samplePostoperative time pointsStatistically significant resultsRelevant articlesWell-beingAnxietyResultsThe inclusion criteriaWomenMastectomySignificant resultsSurgical choiceSurgical decision
2020
Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis
Spring L, Fell G, Arfe A, Sharma C, Greenup R, Reynolds K, Smith B, Alexander B, Moy B, Isakoff S, Parmigiani G, Trippa L, Bardia A. Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis. Clinical Cancer Research 2020, 26: 2838-2848. PMID: 32046998, PMCID: PMC7299787, DOI: 10.1158/1078-0432.ccr-19-3492.Peer-Reviewed Original ResearchConceptsPathologic complete responseEvent-free survivalBetter event-free survivalNeoadjuvant chemotherapyAdjuvant chemotherapyOverall survivalComplete responseBreast cancerImproved event-free survivalIndividual patient-level dataAdditional adjuvant therapySubsequent adjuvant chemotherapyBreast cancer recurrencePatient-level dataComprehensive Meta-AnalysisAdjuvant settingNeoadjuvant responseAdjuvant therapyMicrometastatic diseaseImproved survivalPrognostic significanceSystemic clearanceCancer recurrenceInclusion criteriaChemotherapy